Skip to main content

Advertisement

Log in

Risk of primary lung cancer after breast cancer radiotherapy: a systematic review and meta-analysis

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

Epidemiological studies have shown that the risk of secondary malignancies may increase by radiotherapy. Lung cancer is the most important long-term complication of breast cancer radiotherapy.

Methods

Major electronic databases including Scopus, Web of Science, and MEDLINE were searched. All cohort studies that investigated the association between radiotherapy for breast cancer and risk of primary lung, bronchus, and trachea cancers conducted until March 2021 were included. The study participants were evaluated regardless of their age and ethnicity. The Newcastle–Ottawa Scale was used to assess the quality of the studies. The designated effects were risk ratio (RR). The random-effects model was used to estimate the average effects.

Results

Fifteen studies including 1,640,247 women with primary breast cancer were identified of which 937,151 had not received radiotherapy and 703,096 subjects had received radiotherapy. In general, there was no significant association between breast cancer radiotherapy and lung cancer based on 10 studies (RR = 0.95, 95% CI 0.87–1.02, P = 0.15), There was no association between breast cancer radiotherapy and lung, bronchus, and trachea cancers either based on 5 studies (RR = 0.98, 95% CI 0.93–1.02, P = 0.32).

Conclusion

Radiotherapy for breast cancer is not associated with an excess risk of lung cancer. Due to the limited number of studies, lack of data regarding smoking status, and substantial variation in exposure of the lungs in breast cancer radiotherapy worldwide, further investigations based on randomized controlled trials are suggested to address the potential risk of lung cancer after breast cancer radiotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Group TC. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–16.

    Article  Google Scholar 

  2. McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014. https://doi.org/10.1016/S0140-6736(14)60488-8.

    Article  PubMed  Google Scholar 

  3. Overgaard M, Jensen M-B, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353(9165):1641–8.

    Article  CAS  Google Scholar 

  4. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087–106.

    Article  CAS  Google Scholar 

  5. Lind PA, Marks LB, Jamieson TA, Carter DL, Vredenburgh JJ, Folz RJ, et al. Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue. Cancer. 2002;94(11):2821–9.

    Article  Google Scholar 

  6. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014;15(1):23–34.

    Article  Google Scholar 

  7. Vogelius IR, Bentzen SM. A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol. 2012;51(8):975–83.

    Article  Google Scholar 

  8. Shaitelman SF, Howell RM, Smith BD. The effects of smoking on late toxicity from breast radiation. J Clin Oncol. 2017;35(15):1633.

    Article  Google Scholar 

  9. Tubiana M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol. 2009;91(1):4–15.

    Article  Google Scholar 

  10. Evans H, Lewis C, Robinson D, Bell C, Møller H, Hodgson S. Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer. 2001;84(3):435–40.

    Article  CAS  Google Scholar 

  11. Taylor C, Correa C, Duane FK, Aznar MC, Anderson SJ, Bergh J, et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35(15):1641.

    Article  Google Scholar 

  12. Peterson J, Welch V, Losos M, Tugwell PJ. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2011. p. 1–2.

  13. Poorolajal J, Jenabi E, Masoumi SZ. Body mass index effects on risk of ovarian cancer: a meta-analysis. Asian Pac J Cancer Prev. 2014;15(18):7665–71.

    Article  Google Scholar 

  14. Duval S, Tweedie R. A nonparametric “trim and fill” method of accounting for publication bias in meta-analysis. J Am Stat Assoc. 2000;95(449):89–98.

    Google Scholar 

  15. Andersson M, Storm HH, Mouridsen HT. Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst. 1991;83(14):1013–7.

    Article  CAS  Google Scholar 

  16. Burt LM, Ying J, Poppe MM, Suneja G, Gaffney DK. Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results. Breast. 2017;35:122–9.

    Article  Google Scholar 

  17. De Gonzalez AB, Curtis R, Gilbert E, Berg C, Smith S, Stovall M, et al. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer. 2010;102(1):220–6.

    Article  Google Scholar 

  18. Grantzau T, Mellemkjaer L, Overgaard J. Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG). Radiother Oncol. 2013;106(1):42–9.

    Article  Google Scholar 

  19. Huang Y-J, Huang T-W, Lin F-H, Chung C-H, Tsao C-H, Chien W-C. Radiation therapy for invasive breast cancer increases the risk of second primary lung cancer: a nationwide population-based cohort analysis. J Thorac Oncol. 2017;12(5):782–90.

    Article  Google Scholar 

  20. Kamigaki Y, Kawakami K. Risk of second cancer after initial treatment of breast cancer: an Osaka Cancer Registry Database study. Oncol Lett. 2011;2(5):963–73.

    PubMed  PubMed Central  Google Scholar 

  21. Lavey RS, Eby NL, Prosnitz LR. Impact of radiation therapy and/or chemotherapy on the risk for a second malignancy after breast cancer. Cancer. 1990;66(5):874–81.

    Article  CAS  Google Scholar 

  22. Levi F, Randimbison L, Te VC, La Vecchia C. Cancer risk after radiotherapy for breast cancer. Br J Cancer. 2006;95(3):390–2.

    Article  CAS  Google Scholar 

  23. Murakami R, Hiyama T, Hanai A, Fujimoto I. Second primary cancers following female breast cancer in Osaka, Japan—a population-based cohort study. Jpn J Clin Oncol. 1987;17(4):293–302.

    PubMed  Google Scholar 

  24. Neugut AI, Lee WC, Murray T, Robinson E, Karwoski K, Kutcher GJ. Lung cancer after radiation therapy for breast cancer. Cancer. 1993;71(10):3054–7.

    Article  CAS  Google Scholar 

  25. Roychoudhuri R, Evans H, Robinson D, Moller H. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer. 2004;91(5):868–72.

    Article  CAS  Google Scholar 

  26. Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Lê MG. Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat. 2000;61(3):183–95.

    Article  CAS  Google Scholar 

  27. Travis LB, Curtis RE, Inskip PD, Hankey BF. Re: Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst. 1995;87(1):60–1.

    Article  CAS  Google Scholar 

  28. Aznar MC, Duane FK, Darby SC, Wang Z, Taylor CW. Exposure of the lungs in breast cancer radiotherapy: a systematic review of lung doses published 2010–2015. Radiother Oncol. 2018;126(1):148–54.

    Article  Google Scholar 

  29. Withrow DR, Morton LM, Curtis RE, Schonfeld SJ, Berrington de Gonzalez A. Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers. Breast Cancer Res Treat. 2017;166(1):299–306.

    Article  Google Scholar 

  30. Wu GX, Nelson RA, Kim JY, Raz DJ. Non-small cell lung cancer as a second primary among patients with previous malignancy: who is at risk? Clin Lung Cancer. 2017;18(5):543-50 e3.

    Article  Google Scholar 

  31. Baik CS, Strauss GM, Speizer FE, Feskanich D. Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses’ Health Study. Cancer Epidemiol Biomarkers Prev. 2010;19(10):2525–33.

    Article  Google Scholar 

  32. Poorolajal J. Equivalence model: a new graphical model for causal inference. Epidemiol Health. 2020;42: e2020024.

    Article  Google Scholar 

  33. Pirie K, Peto R, Reeves GK, Green J, Beral V, Collaborators MWS. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet. 2013;381(9861):133–41.

    Article  Google Scholar 

  34. Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med. 2013;368:351–64.

    Article  CAS  Google Scholar 

  35. Grantzau T, Overgaard J. Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: a systematic review and meta-analysis of population-based studies including 522,739 patients. Radiother Oncol. 2016;121(3):402–13.

    Article  Google Scholar 

Download references

Funding

This work was supported by the Vice-Chancellor of Research and Technology, Hamadan University of Medical Sciences. The supporter had no role in study design, data collection, analysis, interpretation, or writing of the report.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jalal Poorolajal.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zareie, B., Rasouli, M.A. & Poorolajal, J. Risk of primary lung cancer after breast cancer radiotherapy: a systematic review and meta-analysis. Breast Cancer 29, 361–367 (2022). https://doi.org/10.1007/s12282-021-01318-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-021-01318-w

Keywords

Navigation